期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

葸环类药物在乳腺癌治疗中的新进展

暂未订购
导出
摘要 过去30年，蒽环类药物广泛用于乳腺癌的治疗，早期乳腺癌研究协作组所做的meta分析更是确定了其价值。然而最近一些研究发现蒽环类对于HER2基因扩增以及TOP2A变异的患者更有效，
作者 徐玉瑞（综述） 巢琳（审校） 陈力平（审校）
机构地区 南京医科大学附属无锡市第二人民医院普外科
出处 《医学临床研究》 CAS 2010年第8期1486-1489,共4页 Journal of Clinical Research
关键词 乳腺肿瘤/药物疗法 抗生素类 蒽环/治疗应用 综述文献
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献33

  • 1Clarke M, Collins R, Darby S, a al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials[J]. Lancet , 2005,366 (9503) : 2087- 2106.
  • 2Pritehard KI, Shepherd LE, O'Malley FP, et al . HER2 and responsiveness of breast cancer to adjuvant chemotherapy[J]. N Engl J Med ,2006,354(20) :2103-2111.
  • 3O'Malley FP, Chia S, Tu D, et al . Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy [J]. J Natl Cancer lnst ,2009,101(9):644-650.
  • 4Orlando L, Del Curto B, Gandini S, et al . Topoisomerase II alpha gene status and prediction of pathological complete remission after anthracyeline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancer [J]. Breast ,2008,17(5) :506-511.
  • 5Tanner M, Isola J, Wiklund T, et al. Topoisomerase II alpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandi- navian Breast Group Trial 9401[J].J Clin Oncol , 2006,24 (16) :2428-2436.
  • 6Tubbs R, Barlow WE, Budd GT, et al . Outcome of patients with early-stage breast eaneer treated with doxorubiein-based adjuvant chemotherapy as a funetion of HER2 and TOP2A status[J]. J Clin Oncol ,2009,27(24) :3881-3886.
  • 7Ryberg M, Nielsen D, Cortese G, et al. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients[J], j Natl Cancer lnst, 2008, 100 (15) :1058-1067.
  • 8Doyle JJ, Neugut AI, Jaeobson JS, et al . Chemotherapy and cardiotoxicity in older breast cancer patients: a population- based study[J]. J Clin Oncol , 2005,23 (34) : 8597-8605.
  • 9Sng JH. Molecular cloning and characterization of the human topoisomerase II alpha and II beta genes: Evidence for isoform evolution through gene duplication[J]. Biochim Biophys Acta ,1999,1444(3) :395-406.
  • 10Kellner U, Sehested M, Jensen PB, et al . Culprit and victim -DNA topoisomerase II [J].Lancet Oncol , 2002,3 (4) : 235- 243.

二级参考文献18

  • 1<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量：167
  • 2Bozionellou V,Mavroudis D,Perraki M,et al.Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone and bone marrow of patients with breast cancer[J].Clin Cancer Res,2004,10(24):8185-8194.
  • 3Bozzetti C,Nizzoli R,Guazzi A,et al.HER-2/neu amplification detected by fluorescence in situ hybridization in fine needle aspirates from primary breast cancer[J].Ann Oncol,2002,13(9):1398-1403.
  • 4Press MF,Sauter G,Bernstein L,et al.Diagnostic evaluation of HER-2 as a molecular target:an assessment of accuracy and reproducibility of laboratory testing in large,prospective,randomized clinical trials[J].Clin Cancer Res,2005,11(18):6598-6607.
  • 5Vogel CL,Reddy JC,Reyno LM.Efficacy of trastuzumab[J].Cancer Res,2005,65(5):2044.
  • 6Slamon DJ,Romond EH,Perez EA.Advances in adjuvant therapy for breast cancer[J].Clin Adv Hematol Oncol,2006,4(3):suppl 1,4-9.
  • 7Nabhohtz JM,Slamon n New adjuvant strategies for breast cancer:meeting the challenge of integrating chemotherapy and trastuzumab (Herceptin)[J].Semin Oncol,2001,28(1 Suppl 3):1-12.
  • 8Lan C,Liu JM,Liu TW,et al.erbB2 amplification by fluorescence in situ hybridization in breast cancer specimens read as 2+ in immunohistochemical analysis[J].Am J Clin Pathol,2005,124(1):97-102.
  • 9Dolan M,Snover D.Comparison of immunohistochemical and fluorescence in situ hybridization assessment of HER-2 status in routine practice[J].Am J Clin Pathol,2005,123(5):766-770.
  • 10Gupta D, Middleton L P,Whitaker M J, Abrams J. Comparison of fluorescence and chromogenic in situ hybridization for detection of HER-2/neu oncogene in breast cancer[J]. Am J Clin Pathol, 2003,119: 381-387.

共引文献21

医学临床研究
2010年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部